Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients

Clinical and Experimental Immunology

Volumn 128, Issue 1, 2002, Pages 175-180

  Ankersmit, H J ^a   Moser, B ^a,c   Zuckermann, A ^a   Roth, G ^a   Taghavi, S ^a   Brunner, M ^a   Wolner, E ^a   Boltz Nitulescu, G ^b,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Apoptosis; Heart transplant; Histones; Soluble TNFR1; T lymphocytes

Indexed keywords

7 AMINODACTINOMYCIN; AZATHIOPRINE; CYCLOSPORIN A; FAS ANTIGEN; FAS LIGAND; HISTONE; INTERLEUKIN 2 RECEPTOR ANTIBODY; LIPOCORTIN 5; OKT 3; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

APOPTOSIS; ARTICLE; BLOOD ANALYSIS; CELL DEATH; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOSUPPRESSIVE TREATMENT; INTRAVASCULAR ULTRASOUND; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE ACTIVATION; VASCULAR DISEASE;

ADULT; ANNEXIN A5; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD95; ANTILYMPHOCYTE SERUM; APOPTOSIS; CELLS, CULTURED; FAS LIGAND PROTEIN; GRAFT REJECTION; HEART TRANSPLANTATION; HISTONES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MUROMONAB-CD3; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0036247993     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01836.x     Document Type: Article

References (34)

1. Cardiac allograft vasculopathy, relationship with acute cellular rejection and histocompatability
2. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients
3. The role of anti-HLA antibodies in heart transplantation
4. Acute rejection, significance of elapsed time after transplantation
5. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
6. Antilymphocyte globulins and monoclonal antibodies
7. One-month prophylactic use of OKT3 in cadaver kidney transplant recipients
8. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody
9. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins
10. Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathway
11. MHC class I ligation of human T cells activates the ZAP-70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 ξ-chain, and induces apoptosis
12. CD2-induced apoptosis in activated human peripheral T cells: A Fas-independent pathway that requires early protein tyrosine phosphorilation
13. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors
14. CD45 ligation induces programmed cell death in T and B lymphocytes
15. CTLA4 mediates antigen-specific apoptosis of human T cells
16. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes
17. Mature T lymphocytes apoptosis, immune regulation in a dynamic and unpredictable antigenic environment
18. Impaired T-cell function, increased soluble death-inducing receptors, and activation-induced T-cell death in patients undergoing haemodialysis
19. Activation-induced cell death and immune dysfunction after implantation of left-ventricular assist device
20. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model
21. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy
22. Interleukin 2 and its receptors: Recent advances and new immunological functions
23. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: Implications for XSCID and XCID
24. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts
25. The use of antibodies against the IL-2 receptor in transplantation
26. Induction of rapid histone degradation by the cytotoxic T lymphocyte protease granzyme A
27. CD95 (APO-1/Fas) -mediated apoptosis, live and let die
28. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets, correlation with Bcl-2 expression and consequences for AIDS pathogenesis
29. Inhibition of death receptor signals by cellular FLIP
30. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis
31. Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients
32. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
33. The TNF and TNF receptor superfamilies: Integrating mammalian biology
34. Tumor necrosis factor. A pleiotropic cytokine therapeutic target